



Non communicable diseases (NCDs) are responsible for 
the majority of mortality worldwide. Cancer, as an NCD is 
expected to be the leading contributor to mortality and the 
number one barrier to increasing life expectancy in every 
country of the world in the 21st century.[1] Cancer ranks 
second among the major causes of death worldwide and was 
responsible for about 9 million deaths in 2015.[2] Globally, 
approximately 1 out of 6 deaths are believed to be caused 
by cancer.[2] In the low human development index (HDI) 
countries of the world, it is one of the three leading causes 
of death.[2]
About 60% of the world’s annual total new cancer cases 
occur in Africa, Asia, Central, and South America, where 
70% of world cancer deaths also occur.[3] The total number 
of cancer deaths in Africa was 72% in 2012 compared to a 
mortality of 42% in Europe.[4] According to the World Health 
Organization (WHO), 12.5% of all deaths are due to cancer. If 
this ongoing pattern continues unabated, it is estimated that, by 
2020, 16 million new cases will be diagnosed annually, with 
70% of these cases occurring in low‑HDI countries where 
there are poor health facilities and unreliable statistics on the 
patterns and trends of cancer.[3]
Despite the undisputable grave threat of cancer to Sub-Saharan 
Africa, many countries in this region have little or no reliable 
data on cancer incidence, the region accounting for only 1% 
of the world cancer registries in 2012.[4,5] Similarly, only five 
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African countries contributed data to the International Agency 
for Research on Cancer by 2015.[5]
The Center for Disease Control and the WHO has stressed 
the importance of high-quality population-based cancer data 
in describing cancer burden, patterns, and outcomes to inform 
cancer prevention, detection and control activities.[6,7]
Cancer registration in Nigeria commenced in 1960 but 
has undergone severe retrogression for various reasons, 
especially between the 70s and 2000s.[8-11] The establishment 
of the Nigerian National System of Cancer Registries in 
2009 has helped in attempts to resurrect cancer registration 
in the country; currently, there are 13 population-based 
cancer registries in the country.[12,13] Data from departmental 
or hospital cancer registries, though largely inferior to 
population-based registries, could be used to extrapolate the 
likely cancer burden in the community.[14,15]
MaterIals and Methods
This is a retrospective descriptive study of all records of 
cancer cases entered into the register of the Department of 
Histopathology, Abubakar Tafawa Balewa University Teaching 
Hospital (ATBUTH), Bauchi, between January 1, 2011 and 
December 31, 2019. The hospital is a 700-bed capacity tertiary 
health facility located in Bauchi, Bauchi state in North-eastern 
Nigeria. It is the only health institution in the state offering 
Pathology services and it receives specimens and referred 
patients from all the state-owned hospitals, private hospitals, 
as well as hospitals from bordering towns and villages in 
neighboring states.
All records of patients diagnosed with any form of cancer 
within the period of study were retrieved from the departmental 
cancer registers. The stored histology and cytology slides 
were retrieved and reviewed by the pathologists. The cases 
were cross‑checked to see which patients benefited from 
both services so that such were counted as single cases. The 
malignant cases were grouped according to ages, sex, and 
body organs and the data analyzed for age, sex, yearly trend, 
and histological types. The results were presented as simple 
frequency tables and charts.
Ethical clearance was obtained from the Research and Ethics 
Committee (REC) of ATBUTH, Bauchi.
ATBUTH REC No: 001/2018.
results
A total of 1284 cases of cancer were recorded over the nine 
years of study, with an average annual frequency rate of 
142.7 cases per annum. The total annual cases ranged from 
39 in 2011 to 206 cases in 2019, with a steady increase in 
the number of cancer cases, as depicted in Figure 1. Females 
accounted for 61.2% (786 cases) of the total cases, while 
38.8% (498 cases) were males. The male: female ratio was 
1:1.6. The age range of cancer cases ranged between seven 
months and 95 years, with a mean of 49.6 ± 18 years and a 
median age of 50 years.
The age was unspecified in 30 cases. The modal age group of 
occurrences was the age group 40–49 years, accounting for 
18.9% of cases.
The three most frequent age groups of cancer occurrence 
were the 40–49, 50–59, and 60–69 years age groups (fifth to 
seventh decades of life), accounting for a combined frequency 
of 712 (55.5%) cases [Figure 2]. Furthermore, children and 
adolescent (teenage) cancer cases (0–19 years) accounted for 
4.4% of cases.
The top five common cancers irrespective of sex were cancers 
of the cervix (18.1%), breast (14.9%), prostate (13.9%), 
nonmelanoma skin (7.7%), and ovary (4.8%).
The five most common cancers in females are cancers of 
the cervix uteri (29.6%), breast (23.5%), ovary (7.8%), 
placenta (5.7%), and nonmelanoma skin (4.8%). In males, the 
five most common cancers are those of the prostate (35.7%), 
nonmelanoma skin (12.2%), colorectum (7.8%), urinary 
bladder (6.6), and soft tissue (6.0%). Table 1 and 
Figures 3, 4 show the distribution of total cancer cases by sex 
and site of occurrence.
In children and adolescents, the top five commonly 
diagnosed cancer cases were cancers of the lymph nodes, 
soft tissue, skin, eye, and kidneys in descending order of 
frequency [Figure 5].
dIscussIon
The present study demonstrated an upward trend in the 
prevalence of cancer for over nine years. While this can be 
attributable to an improvement in diagnosis and treatment 
facilities, especially the recent increase in awareness and 
screening of cervical, breast and prostate cancers in the state, 
other yet to be determined factors might be responsible for the 
recent upsurge in other types of cancers. Zayyan et al.[16] in 
2017 reported an increasing trend in cases of ovarian cancer 
in Zaria between 2004 and 2013. Jedy-Agba et al.,[10] in their 
comparative analysis of Abuja and Ibadan population-based 
cancer registries data from 2009 to 2010, also observed 
increasing incidence rates of cancer from the two centres 
compared to previous data. A study from Kano also showed 
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Figure 1: Annual frequency of cancer cases
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increasing trends of cancer in the population.[17] The increase 
in rates was particularly remarkable for breast cancer which 
recorded >100% increase within a decade.[17] Available 
literature also supports an increasing trend of breast cancer in 
sub-Saharan Africa, with most of the increases in incidence 
in the region being thought to be a reflection of the increasing 
lifespan of women and adoption of lifestyles that favor higher 
incidence rates.[18] Even though some of the general increase 
in cancer incidence rates can be attributed to improving 
health care delivery system that aids early diagnosis through 
screening, as well as improved access to health care and 
awareness made possible through health education in recent 
years, cases of a real increase due to an expanding prevalence 
in risk factors for some of these hitherto low incidence cancers, 
are a possibility.
A majority (61.2%) of the cancer cases were diagnosed in 
females with male cancers accounting for 38.8% of cases. This 
is not unexpected considering that the two commonest cancers, 
namely, those of the cervix and breast, occur either exclusively 
in females (cancer of the cervix) or occur only negligibly in 
males (breast cancer). Our finding is in agreement with reports 
from other parts of Nigeria. The National Cancer Incidence 
studies that were based on data from population-based 
registries show that the distribution of cancers in females 
and males were 61.5% and 38.5%, respectively.[13] Several 
hospital-based cancer registries across the country also 
reported figures that show the predominant occurrence of 
cancers in females compared to those of males.[13] This is in 
sharp contrast to reports from high-HDI countries of the US 
and UK, where in addition to prevalence, the mortalities are 
also more in males than females.[19,20] This contrast may not be 
unconnected with the organ distribution of the most common 
cancer cases in these two economies. While cervical cancer 
cases have reduced significantly in the high‑HDI countries 
over the past five decades due to effective screening programs 
for detection and treatment of precancerous lesions as well as 
immunization programs for the human papillomavirus, the 
majority of the low-HDI nations of the world are yet to have 
such organized programs in place.[21]
The age range in this study is from seven months to 95 years 
of age with the modal age of cases in the fifth decade of life, 
about two decades earlier than what is obtainable in the UK 
where >50% of their cancer cases are seen after the age of 
70 years.[20]
The findings from this study show that the five most 
common cancers in women were cervical, breast, ovarian, 
placental choriocarcinoma, and nonmelanoma skin cancers, 
in descending order of frequency. This finding only partially 
agrees with the national incidence statistics (2009–2013) 
that showed that the top five cancers in Nigerian women 
were breast, cervical, ovarian, colorectal, and soft-tissue 
cancers.[13] Furthermore, the most common cancer in females 
in this study was cervical cancer, in contrast to the national 
incidence statistics and several other institutional-based 
reports across the country that showed that breast cancer 
was the most common cancer in females ahead of cervical 











Urinary bladder 41 (3.2)
Lymph node 37 (2.9)
Uterus (corpus, nongestational) 32 (2.5)
Skin-melanoma 31 (2.4)
Eye (and ocular adnexa) 27 (2.1)
Anus/anorectum/perianal 23 (1.8)






Salivary gland 7 (0.5)
Nasal cavity/sinus 5 (0.4)
Liver 5 (0.4)














Unknown site 8 (0.6)
Total 1284 (100.0)
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Figure 2: Age distribution of cancer cases
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cancer, as reported by Ogunbiyi in Ibadan,[22] Malami et al. in 
Sokoto,[23] Yusuf et al. in Kano,[24] and Mandong et al. in Jos.[25] 
While most hospital-based registries report breast cancer as 
the most common cancer in females, reports from Kogi and 
Nasarawa states show that cancer of the cervix is the most 
common female cancer in those areas.[13] Researchers from a 
few Sub-Saharan African countries also reported cancer of the 
cervix to be the most common cancer in women.[14,26] Thus, 
it would appear that there are variations in the prevalence 
of breast and cervical cancer between states in Nigeria. In 
addition, while the exact position of breast and cervical cancer 
may vary, it is undoubtedly clear that these two cancers account 
for the overwhelming majority of cancers in women in Nigeria. 
In this study, for example, they together accounted for more 
than half of cancers in women.
The most common cancers in males in this report are prostate, 



























































































































































































































































































































































































































































































Figure 5: Distribution of cancer cases in children and adolescents (0–
19 years)
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cancers in descending order of frequency. This agrees to some 
extent with the national incidence statistics that list the top 
five male cancers to be cancers of the prostate, colorectum, 
nonmelanoma skin, liver, and soft tissues. In males, the most 
common cancer is that of the prostate, accounting for about 
14% of all cancers and 36% of male cancers in this report. 
The national incidence statistics and several studies within the 
country, as well as reports from other countries of sub-Saharan 
Africa, are in agreement with our findings.[13,17,22,23] Liver 
cancer, which is the 4th commonest cancer in men, according 
to the national data, is distinctly uncommon in our report, with 
liver cancer being the 20th most common cancer in men. The 
reason for this wide disparity may be because a substantial 
proportion of cases of suspected liver cancer are diagnosed 
clinically and biochemically without liver biopsy and very 
little if any postmortem examination for patients who die of 
chronic liver disease, resulting in an underrepresentation of 
liver cancer.
Lung cancer, which is the most common cancer in men 
worldwide, is extremely rare in this report, with only a single 
case documented over nine years. The reason for the very low 
level of lung cancer recorded, apart from the paucity of experts 
in cardiothoracic surgery in the region, might be as a result of 
a relatively low level of tobacco smoking among the people 
in our area of study.
conclusIons
Departmental cancer registries, while providing useful 
information on cancers, are deficient in reflecting the total 
number of cancer cases within an institution or community. The 
diagnoses of certain cancers, such as leukaemias, are usually 
not based on tissue histology or cytology and are likely to be 
grossly under-represented in departmental pathology registers.
There is a need to have an organized hospital-based cancer 
registry in ATBUTH, Bauchi, to better document cancer 
cases in the institution. This could be later expanded to a 
population‑based cancer registry to fulfil the ultimate goal of 
having accurate data on cancer in our environment to allow for 
the formulation of relevant policies and planning for cancer 
prevention and control in the region.
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